Impaired glucose-induced glucagon suppression after partial ...

18. Menge BA, Schrader H, Breuer TGK, Dabrowski Y, Uhl W, Schmidt WE, Meier
JJ 2008 Metabolic consequences of a 50% partial pancreatectomy in humans.
Diabetologia 52:306-317
19. Meier JJ, Hücking K, Holst JJ, Deacon C, Schmiegel W, Nauck MA 2001
Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives
of patients with type 2 diabetes. Diabetes 50:2497-2504
20. Meier JJ, Gallwitz B, Siepmann N, Holst JJ, Deacon CF, Schmidt WE, Nauck
MA 2003 Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon
secretion in healthy human subjects at euglycaemia. Diabetologia 46:798-801
21. Holst JJ 1997 Enteroglucagon. Annu Rev Physiol 59:257-271
22. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral
glucose tolerance testing. Diabetes Care 22:1462-1470
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC
1985 Homeostasis model assessment: Insulin resistance and ß-cell function from
fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
24. Hope KM, Tran PO, Zhou H, Oseid E, Leroy E, Robertson RP 2004 Regulation of
alpha-cell function by the beta-cell in isolated human and rat islets deprived of
glucose: the "switch-off" hypothesis. Diabetes 53:1488-1495.
25. Seaquist ER, Robertson RP 1992 Effects of hemipancreatectomy on pancreatic
alpha and beta cell function in healthy human donors. J Clin Invest 89:1761-1766.
26. Ohneda A, Parada E, Eisentraut AM, Unger RH 1968 Characterization of response
of circulating glucagon to intraduodenal and intravenous administration of amino
acids. J Clin Invest 47:2305-2322.
27. Muller WA, Faloona GR, Aguilar-Parada E, Unger RH 1970 Abnormal alpha-cell
function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med
283:109-115.
28. Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W 1993
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36
amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:741-744.
29. Meier JJ, Gallwitz B, Siepmann N, Holst JJ, Deacon CF, Schmidt WE, Nauck
MA 2003 Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon
secretion in healthy human subjects at euglycaemia. Diabetologia 46:798-801. Epub
2003 May 2023.
30. Creutzfeldt W, Feurle G, Ketterer H 1970 Effect of gastrointestinal hormones on
insulin and glucagon secretion. N Engl J Med 282:1139-1141.
31. Unger RH, Ketterer H, Dupre J, Eisentraut AM 1967 The effects of secretin,
pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs. J
Clin Invest 46:630-645.
32. Banarer S, McGregor VP, Cryer PE 2002 Intraislet hyperinsulinemia prevents the
glucagon response to hypoglycemia despite an intact autonomic response. Diabetes
51:958-965.
33. Samols E, Stagner JI, Ewart RB, Marks V 1988 The order of islet microvascular
cellular perfusion is B----A----D in the perfused rat pancreas. J Clin Invest 82:350-
353.
34. Franklin I, Gromada J, Gjinovci A, Theander S, Wollheim CB 2005 Beta-cell
secretory products activate alpha-cell ATP-dependent potassium channels to inhibit
glucagon release. Diabetes 54:1808-1815.
35. Diao J, Asghar Z, Chan CB, Wheeler MB 2005 Glucose-regulated glucagon
secretion requires insulin receptor expression in pancreatic alpha-cells. J Biol Chem
280:33487-33496. Epub 32005 Jul 33414.
16